Srivastava Deepak 4
4 · Tenaya Therapeutics, Inc. · Filed Dec 9, 2022
Insider Transaction Report
Form 4
Srivastava Deepak
Director
Transactions
- Purchase
Common Stock
2022-11-21$2.60/sh+230,769$599,999→ 372,435 total(indirect: See Footnote)
Holdings
- 191,666
Common Stock
Footnotes (1)
- [F1]These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.